0001564590-19-017426.txt : 20190509 0001564590-19-017426.hdr.sgml : 20190509 20190508184749 ACCESSION NUMBER: 0001564590-19-017426 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invesco CurrencyShares Swiss Franc Trust CENTRAL INDEX KEY: 0001353615 STANDARD INDUSTRIAL CLASSIFICATION: [6221] IRS NUMBER: 000000000 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32907 FILM NUMBER: 19808233 BUSINESS ADDRESS: STREET 1: C/O INVESCO SPECIALIZED PRODUCTS STREET 2: 3500 LACEY ROAD, SUITE 700 CITY: DOWNERS GROVE STATE: IL ZIP: 60515 BUSINESS PHONE: 800-983-0903 MAIL ADDRESS: STREET 1: C/O INVESCO SPECIALIZED PRODUCTS STREET 2: 3500 LACEY ROAD, SUITE 700 CITY: DOWNERS GROVE STATE: IL ZIP: 60515 FORMER COMPANY: FORMER CONFORMED NAME: CURRENCYSHARES SWISS FRANC TRUST DATE OF NAME CHANGE: 20130124 FORMER COMPANY: FORMER CONFORMED NAME: CURRENCYSHARES AUSTRALIAN DOLLAR TRUST DATE OF NAME CHANGE: 20130122 FORMER COMPANY: FORMER CONFORMED NAME: CURRENCYSHARES SWISS FRANC TRUST DATE OF NAME CHANGE: 20060216 10-Q 1 fxf-10q_20190331.htm 10-Q fxf-10q_20190331.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2019

or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ____ to ____

Commission File Number 001-32907

 

Invesco CurrencyShares® Swiss Franc Trust

Sponsored by Invesco Specialized Products, LLC

(Exact name of registrant as specified in its charter)

 

 

New York

 

20-4686336

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer Identification No.)

 

3500 Lacey Road, Suite 700

Downers Grove, Illinois

 

60515

(Address of principal executive offices)

 

(Zip Code)

 

(800) 983-0903

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (d232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

 

 

Accelerated filer

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Units of Beneficial Interest

FXF

NYSE Arca

Indicate the number of outstanding Redeemable Capital Shares as of March 31, 2019: 1,600,000 Shares.

 

 

1


INVESCO CURRENCYSHARES® SWISS FRANC TRUST

INDEX

 

Caption

 

Page

 

 

 

PART I — FINANCIAL INFORMATION

3

 

 

Item 1. Financial Statements (Unaudited)

3

 

 

Statements of Financial Condition at March 31, 2019 and December 31, 2018

3

 

 

Statements of Comprehensive Income for the three months ended March 31, 2019 and the three months ended March 31, 2018

4

 

 

Statements of Changes in Shareholders’ Equity and Redeemable Capital Shares for the three months ended March 31, 2019  

5

 

 

Statements of Changes in Shareholders’ Equity and Redeemable Capital Shares for the three months ended March 31, 2018  

6

 

 

Statements of Cash Flows for the three months ended March 31, 2019 and the three months ended March 31, 2018

7

 

 

Notes to Financial Statements

8

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

12

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

15

 

 

Item 4. Controls and Procedures

15

 

 

Part II — OTHER INFORMATION

16

 

 

Item 1. Legal Proceedings

16

 

 

Item 1A. Risk Factors

16

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

16

 

 

Item 3. Defaults Upon Senior Securities

17

 

 

Item 4. Mine Safety Disclosures

17

 

 

Item 5. Other Information

17

 

 

Item 6. Exhibits

18

 

 

SIGNATURES

20

 

2


PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Invesco CurrencyShares® Swiss Franc Trust

Statements of Financial Condition

(Unaudited)

 

 

 

March 31, 2019

 

 

 

 

December 31, 2018

 

Assets

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

 

 

Swiss Franc deposits, interest bearing

 

$

149,551,411

 

 

 

 

$

175,196,237

 

Swiss Franc deposits, non-interest bearing

 

 

 

 

 

 

 

 

Total Current Assets

 

$

149,551,411

 

 

 

 

$

175,196,237

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Redeemable Capital Shares and Shareholders’ Equity

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

 

Accrued Sponsor’s fee

 

$

50,885

 

 

 

 

$

61,461

 

Accrued interest expense on currency deposits

 

 

97,083

 

 

 

 

 

117,102

 

Total Current Liabilities

 

 

147,968

 

 

 

 

 

178,563

 

Commitments and Contingent Liabilities (note 8)

 

 

 

 

 

 

 

 

Redeemable Capital Shares, at redemption value, no par value,

   29,500,000 authorized – 1,600,000 and 1,850,000 issued and outstanding,

   respectively

 

 

149,403,443

 

 

 

 

 

175,017,674

 

Shareholders’ Equity:

 

 

 

 

 

 

 

 

 

 

Retained Earnings

 

 

 

 

 

 

 

 

Total Liabilities, Redeemable Capital Shares and Shareholders’ Equity

 

$

149,551,411

 

 

 

 

$

175,196,237

 

 

See Notes to Financial Statements.

 

3


Invesco CurrencyShares ® Swiss Franc Trust

Statements of Comprehensive Income

(Unaudited)

 

 

 

Three Months Ended March 31, 2019

 

 

 

 

Three Months Ended March 31, 2018

 

Income

 

 

 

 

 

 

 

 

 

 

Interest Income

 

$

 

 

 

 

$

 

Total Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

Sponsor’s fee

 

 

(155,227

)

 

 

 

 

(152,959

)

Interest Expense on currency deposits

 

 

(295,940

)

 

 

 

 

(290,510

)

Total Expenses

 

 

(451,167

)

 

 

 

 

(443,469

)

Net Comprehensive Income (Loss)

 

$

(451,167

)

 

 

 

$

(443,469

)

Basic and Diluted Earnings per Share

 

$

(0.27

)

 

 

 

$

(0.28

)

Weighted-average Shares Outstanding

 

 

1,678,889

 

 

 

 

 

1,562,222

 

 

See Notes to Financial Statements.

 

4


Invesco CurrencyShares® Swiss Franc Trust

Statements of Changes in Shareholders’ Equity and Redeemable Capital Shares

(Unaudited)

 

 

 

Retained Earnings

 

 

Total Shareholders' Equity

 

 

Redeemable Capital Shares

 

Balance at  December 31, 2018

 

$

 

 

$

 

 

$

175,017,674

 

Purchases of Shares

 

 

 

 

 

 

 

 

9,316,175

 

Redemption of Shares

 

 

 

 

 

 

 

 

(32,867,039

)

Net Increase (Decrease) due to Share Transactions

 

 

 

 

 

 

 

 

(23,550,864

)

Distributions

 

 

 

 

 

 

 

 

 

Net Comprehensive Income (Loss)

 

 

(451,167

)

 

 

(451,167

)

 

 

 

Adjustment of Redeemable Capital Shares to Redemption Value related to Retained Earnings

 

 

451,167

 

 

 

451,167

 

 

 

(451,167

)

Adjustment of Redeemable Capital Shares to Redemption Value

 

 

 

 

 

 

 

 

(1,612,200

)

Balance at  March 31, 2019

 

$

 

 

$

 

 

$

149,403,443

 

 

See Notes to Financial Statements.

5


Invesco CurrencyShares® Swiss Franc Trust

Statements of Changes in Shareholders’ Equity and Redeemable Capital Shares

(Unaudited)

 

 

 

Retained Earnings

 

 

Total Shareholders' Equity

 

 

Redeemable Capital Shares

 

Balance at  December 31, 2017

 

$

 

 

$

 

 

$

150,066,823

 

Purchases of Shares

 

 

 

 

 

 

 

 

9,922,904

 

Redemption of Shares

 

 

 

 

 

 

 

 

 

Net Increase (Decrease) due to Share Transactions

 

 

 

 

 

 

 

 

9,922,904

 

Distributions

 

 

 

 

 

 

 

 

 

Net Comprehensive Income (Loss)

 

 

(443,469

)

 

 

(443,469

)

 

 

 

Adjustment of Redeemable Capital Shares to Redemption Value related to Retained Earnings

 

 

443,469

 

 

 

443,469

 

 

 

(443,469

)

Adjustment of Redeemable Capital Shares to Redemption Value

 

 

 

 

 

 

 

 

2,557,350

 

Balance at  March 31, 2018

 

$

 

 

$

 

 

$

162,103,608

 

 

See Notes to Financial Statements.

 

6


Invesco CurrencyShares® Swiss Franc Trust

Statements of Cash Flows

(Unaudited)

 

 

 

Three Months Ended March 31, 2019

 

 

Three Months Ended March 31, 2018

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net Comprehensive Income (Loss)

 

$

(451,167

)

 

$

(443,469

)

Adjustments to reconcile net comprehensive

     income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

      Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

       Receivable from accrued interest

 

 

 

 

 

 

       Accrued interest expense

 

 

(20,019

)

 

 

3,062

 

       Accrued Sponsor's fee

 

 

(10,576

)

 

 

1,828

 

Net cash used in operating activities

 

 

(481,762

)

 

 

(438,579

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

 

Distributions paid to shareholders

 

 

 

 

 

 

Proceeds from purchases of redeemable Shares

 

 

9,316,175

 

 

 

9,922,904

 

Redemptions of redeemable Shares

 

 

(32,867,039

)

 

 

 

Net cash used in financing activities

 

 

(23,550,864

)

 

 

9,922,904

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate on cash

 

 

(1,612,200

)

 

 

2,557,350

 

Net change in cash

 

 

(25,644,826

)

 

 

12,041,675

 

Cash at beginning of period

 

 

175,196,237

 

 

 

150,214,855

 

Cash at end of period

 

$

149,551,411

 

 

$

162,256,530

 

 

See Notes to Financial Statements.

 

7


Invesco CurrencyShares® Swiss Franc Trust

Notes to Financial Statements

(Unaudited)

1.

Background

On September 28, 2017, Guggenheim Capital, LLC (“Guggenheim”) and Invesco Ltd. entered into a Transaction Agreement (the “Transaction Agreement”), pursuant to which Guggenheim agreed to transfer all of the membership interests of Guggenheim Specialized Products, LLC (the “Sponsor”) to Invesco Capital Management LLC (“Invesco Capital Management”).

The Transaction Agreement was consummated on April 6, 2018 (the “Closing”) and immediately following the Closing, Invesco Capital Management changed the name of the Sponsor to Invesco Specialized Products, LLC.

On January 9, 2019, the Sponsor changed the Trust’s fiscal year from the period beginning on November 1 and ending on October 31 to the period beginning on January 1 and ending on December 31. Unless otherwise noted, all references to “years” in this report refer to the twelve-month fiscal year, which prior to November 1, 2018 ended on October 31 and beginning after December 31, 2018 ends on December 31 of each year.

2.

Organization and Description of the Trust

The Invesco CurrencyShares® Swiss Franc Trust (the “Trust”) was formed under the laws of the State of New York on June 8, 2006 when the Sponsor deposited 100 Swiss Francs in the Trust’s primary deposit account held by JPMorgan Chase Bank, N.A., London Branch (the “Depository”). The Sponsor is a Delaware limited liability company whose sole member is Invesco Capital Management. The Sponsor is responsible for, among other things, overseeing the performance of The Bank of New York Mellon (the “Trustee”) and the Trust’s principal service providers, including the preparation of financial statements. The Trustee is responsible for the day-to-day administration of the Trust.

The investment objective of the Trust is for the Trust’s shares (the “Shares”) to reflect the price in U.S. Dollars (“USD”) of the Swiss Franc plus accrued interest, if any, less the Trust’s expenses and liabilities. The Shares are intended to provide investors with a simple, cost-effective means of gaining investment benefits similar to those of holding Swiss Francs. The Trust’s assets primarily consist of Swiss Francs on demand deposit in two deposit accounts maintained by the Depository: a primary deposit account which may earn interest and a secondary deposit account which does not earn interest. The secondary deposit account is used to account for any interest that may be received and paid out on creations and redemptions of blocks of 50,000 Shares (“Baskets”). The secondary account is also used to account for interest earned, if any, on the primary deposit account, pay Trust expenses and distribute any excess interest to holders of Shares (“Shareholders”) on a monthly basis.

The accompanying unaudited financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission. In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period. These financial statements and the notes thereto should be read in conjunction with the Trust’s financial statements included in the Form 10-K transition report as filed on March 11, 2019.

3.

Significant Accounting Policies

 

A.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets, liabilities and disclosures of contingent liabilities at the date of the financial statements, the reported amounts of revenue and expenses during the period and the evaluation of subsequent events through the issuance date of the financial statements. Actual results could differ from those estimates.

 

B.

Foreign Currency Translation

For Net Asset Value (“NAV”) calculation purposes, Swiss Franc deposits (cash) are translated at the Closing Spot Rate, which is the Swiss Franc/USD exchange rate as determined and published by The WM Company at 4:00 PM (London time / London fixing) on each day that NYSE Arca, Inc. (“NYSE Arca”) is open for regular trading.

8


The Trust maintains its books and records in Swiss Francs. For financial statement reporting purposes, the U.S. Dollar is the reporting currency. As a result, the financial records of the Trust are translated from Swiss Francs to USD. The Closing Spot Rate on the last day of the period is used for translation in the statements of financial condition. The average Closing Spot Rate for the period is used for translation in the statements of comprehensive income and the statements of cash flows. The redeemable capital Shares are adjusted to redemption value and these adjustments are recorded against retained earnings.

 

C.

Federal Income Taxes

The Trust is treated as a “grantor trust” for federal income tax purposes and, therefore, no provision for federal income taxes is required. Interest, gains and losses are passed through to the Shareholders.

Shareholders generally will be treated, for U.S. federal income tax purposes, as if they directly owned a pro-rata share of the assets held in the Trust. Shareholders also will be treated as if they directly received their respective pro-rata portion of the Trust’s income, if any, and as if they directly incurred their respective pro-rata portion of the Trust’s expenses. The acquisition of Shares by a U.S. Shareholder as part of a creation of a Basket will not be a taxable event to the Shareholder.

The Sponsor’s fee accrues daily and is payable monthly. For U.S. federal income tax purposes, an accrual-basis U.S. Shareholder generally will be required to take into account as an expense its allocable portion of the USD-equivalent of the amount of the Sponsor’s fee that is accrued on each day, with such USD-equivalent being determined by the currency exchange rate that is in effect on the respective day. To the extent that the currency exchange rate on the date of payment of the accrued amount of the Sponsor’s fee differs from the currency exchange rate in effect on the day of accrual, the U.S. Shareholder will recognize a currency gain or loss for U.S. federal income tax purposes.

The Trust does not expect to generate taxable income except for interest income (if any) and gain (if any) upon the sale of Swiss Francs. A non-U.S. Shareholder generally will not be subject to U.S. federal income tax with respect to gain recognized upon the sale or other disposition of Shares, or upon the sale of Swiss Francs by the Trust, unless: (1) the non-U.S. Shareholder is an individual and is present in the United States for 183 days or more during the taxable year of the sale or other disposition, and the gain is treated as being from United States sources; or (2) the gain is effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States.

A non-U.S. Shareholder’s portion of any interest income earned by the Trust generally will not be subject to U.S. federal income tax unless the Shares owned by such non-U.S. Shareholder are effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States.

 

D.

Revenue Recognition

Interest on the primary deposit account, if any, accrues daily as earned and is received or paid on a monthly basis. Any interest below zero for the period is reflected as interest expense on currency deposits. The Depository may change the rate at which interest accrues, including reducing the interest rate to zero or below zero, based upon changes in market conditions or based on the Depository’s liquidity needs. Interest charged on the primary deposit account will be disclosed as interest expense on currency deposits.

 

E.

Dividends

To the extent that the interest earned by the Trust, if any, exceeds the sum of the Sponsor’s fee for the prior month plus other Trust expenses, if any, the Trust will distribute, as a dividend (herein referred to as dividends or distributions), the excess interest earned in Swiss Francs effective on the first business day of the subsequent month. The Trustee will direct that the excess Swiss Francs be converted into USD at the prevailing market rate and the Trustee will distribute the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own).

4.

Swiss Franc Deposits

Swiss Franc principal deposits are held in a Swiss Franc-denominated, interest-bearing demand account. The interest rate in effect as of March 31, 2019 was an annual nominal rate of -0.75%. For the three months ended March 31, 2019, there were Swiss Franc principal deposits of 9,312,870, Swiss Franc principal redemptions of 32,604,681 and Swiss Franc withdrawals (to pay expenses) of 478,390, resulting in an ending Swiss Franc principal balance of 148,938,249. This equates to 149,551,411 USD. For the two months ended December 31, 2018, there were Swiss Franc principal deposits of 18,683,840, Swiss Franc principal redemptions of 23,343,201 and Swiss Franc withdrawals (to pay expenses) of 345,547, resulting in an ending Swiss Franc principal balance of 172,708,450. This equates to 175,196,237 USD.

Net interest, if any, associated with creation and redemption activity is held in a Swiss Franc-denominated non-interest-bearing account, and any balance is distributed in full as part of the monthly income distributions, if any.

9


5. Redeemable Capital Shares

Shares are classified as “redeemable” for financial statement purposes, since they are subject to redemption. Shares are issued and redeemed continuously in Baskets in exchange for Swiss Francs. Individual investors cannot purchase or redeem Shares in direct transactions with the Trust. Only Authorized Participants (as defined below) may place orders to create and redeem Baskets. An Authorized Participant is a Depository Trust Company (“DTC”) participant that is a registered broker-dealer or other institution eligible to settle securities transactions through the book-entry facilities of the DTC and which has entered into a contractual arrangement with the Trust and the Sponsor governing, among other matters, the creation and redemption process. Authorized Participants may redeem their Shares at any time in Baskets.

Due to expected continuing creations and redemptions of Baskets and the two-day period for settlement of each creation or redemption, the Trust reflects Shares created as a receivable on the trade date. Shares redeemed are reflected as a liability on the trade date. Outstanding Shares are reflected at a redemption value, which is the NAV per Share at the period end date. Adjustments to redeemable capital Shares at redemption value are recorded directly to redeemable capital shares and retained earnings.

Activity in redeemable capital Shares is as follows:

 

 

Three Months Ended March 31, 2019

 

 

Three Months Ended March 31, 2018

 

 

 

Shares

 

 

U.S. Dollar

Amount

 

 

Shares

 

 

 

 

U.S. Dollar

Amount

 

Opening Balance

 

 

1,850,000

 

 

$

175,017,674

 

 

 

1,550,000

 

 

 

 

$

150,066,823

 

Shares issued

 

 

100,000

 

 

 

9,316,175

 

 

 

100,000

 

 

 

 

 

9,922,904

 

Shares redeemed

 

 

(350,000

)

 

 

(32,867,039

)

 

 

 

 

 

 

 

 

Adjustment of Redeemable Capital Shares to Redemption Value

 

 

 

 

 

(2,063,367

)

 

 

 

 

 

 

 

2,113,881

 

Ending Balance

 

 

1,600,000

 

 

$

149,403,443

 

 

 

1,650,000

 

 

 

 

 

162,103,608

 

The Trustee calculates the Trust’s NAV each business day. To calculate the NAV, the Trustee subtracts the Sponsor’s accrued fee through the previous day from the Swiss Francs held by the Trust (including all unpaid interest, if any, accrued through the preceding day) and calculates the value of the Swiss Francs in USD based upon the Closing Spot Rate. If, on a particular evaluation day, the Closing Spot Rate has not been determined and announced by 6:00 PM (London time), then the most recent Closing Spot Rate will be used to determine the NAV of the Trust unless the Trustee, in consultation with the Sponsor, determines that such price is inappropriate to use as the basis for the valuation. If the Trustee and the Sponsor determine that the most recent Closing Spot Rate is not an appropriate basis for valuation of the Trust’s Swiss Francs, they will determine an alternative basis for the valuation. The Trustee also determines the NAV per Share, which equals the NAV of the Trust, divided by the number of outstanding Shares. Shares deliverable under a purchase order are considered outstanding for purposes of determining NAV per Share; Shares deliverable under a redemption order are not considered outstanding for this purpose.

6.Related Parties

The Sponsor is a related party of the Trust. The Sponsor’s fee accrues daily at an annual nominal rate of 0.40% of the Swiss Francs in the Trust (including all unpaid interest but excluding unpaid fees, each as accrued through the immediately preceding day) and is paid monthly.

The Sponsor assumes and pays the following administrative and marketing expenses incurred by the Trust: the Trustee’s monthly fee, NYSE Arca listing fees, SEC registration fees, typical maintenance and transaction fees of the Depository, printing and mailing costs, audit fees and expenses, up to $100,000 per year in legal fees and expenses, and applicable license fees.

In certain exceptional cases the Trust will pay for some expenses in addition to the Sponsor’s fee. These exceptions include expenses not assumed by the Sponsor (i.e., expenses other than those identified in the preceding paragraph), expenses resulting from negative interest rates, taxes and governmental charges, expenses and costs of any extraordinary services performed by the Trustee or the Sponsor on behalf of the Trust or action taken by the Trustee or the Sponsor to protect the Trust or the interests of Shareholders, indemnification of the Sponsor under the Depositary Trust Agreement, audit fees and legal expenses in excess of $100,000 per year.

7.

Concentration Risk

All of the Trust’s assets are Swiss Francs, which creates a concentration risk associated with fluctuations in the price of the Swiss Franc. Accordingly, a decline in the Swiss Franc to USD exchange rate will have an adverse effect on the value of the Shares. Factors that may have the effect of causing a decline in the price of the Swiss Franc include national debt levels and trade deficits, domestic and foreign inflation rates, domestic and foreign interest rates, investment and trading activities of institutions and global or regional political, economic or financial events and situations. Substantial sales of Swiss Francs by the official sector (central banks, other

10


governmental agencies and related institutions that buy, sell and hold Swiss Francs as part of their reserve assets) could adversely affect an investment in the Shares.

All of the Trust’s Swiss Francs are held by the Depository. Accordingly, a risk associated with the concentration of the Trust’s assets in accounts held by a single financial institution exists and increases the potential for loss by the Trust and the Trust’s beneficiaries in the event that the Depository becomes insolvent.

8.

Commitments and Contingencies

The Trust’s organizational documents provide for the Trust to indemnify the Sponsor and any affiliate of the Sponsor that provides services to the Trust to the maximum extent permitted by applicable law, subject to certain exceptions for disqualifying conduct by the Sponsor or such an affiliate. The Trust’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Trust that have not yet occurred. Further, the Trust has not had prior claims or losses pursuant to these contracts. Accordingly, the Sponsor expects the risk of loss to be remote.

 

 

11


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward-Looking Information

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “seek,” “outlook” and “estimate” and other similar words. Forward-looking statements are based upon our current expectations and beliefs concerning future developments and their potential effects on us. Such forward-looking statements are not guarantees of future performance. Various factors may cause our actual results to differ materially from those expressed in our forward-looking statements. These factors include fluctuations in the price of the Swiss Franc, as the value of the Shares relates directly to the value of the Swiss Francs held by the Trust and price fluctuations could materially adversely affect an investment in the Shares. Readers are urged to review the “Risk Factors” section contained in the Trust’s most recent annual report on Form 10-K for a description of other risks and uncertainties that may affect an investment in the Shares.

Neither Invesco Specialized Products, LLC (the “Sponsor”) nor any other person assumes responsibility for the accuracy or completeness of forward-looking statements contained in this report. The forward-looking statements are made as of the date of this report, and will not be revised or updated to reflect actual results or changes in the Sponsor’s expectations or predictions.

Trust Overview

The Invesco CurrencyShares® Swiss Franc Trust (the “Trust”) is a grantor trust that was formed on June 8, 2006. The Trust issues shares (the “Shares”) in blocks of 50,000 (a “Basket”) in exchange for deposits of Swiss Francs and distributes Swiss Francs in connection with the redemption of Baskets. The Shares commenced trading on the New York Stock Exchange under the ticker symbol “FXF” on June 26, 2006. The primary listing of the Shares was transferred to NYSE Arca on October 30, 2007.

The investment objective of the Trust is for the Shares to reflect the price in USD of the Swiss Franc plus accrued interest, if any, less the expenses of the Trust’s operations. The Shares are intended to offer investors an opportunity to participate in the market for the Swiss Franc through an investment in securities. The Shares are intended to provide institutional and retail investors with a simple, cost-effective means of gaining investment benefits similar to those of holding the Swiss Franc. The Shares are bought and sold on NYSE Arca like any other exchange-listed security. The Shares are backed by the assets of the Trust, which does not hold or use derivative products. The Trust is a passive investment vehicle and does not have any officers, directors or employees. The Trust does not engage in any activities designed to obtain profit from, or ameliorate losses caused by, changes in the price of the Swiss Franc. Investing in the Shares does not insulate the investor from certain risks, including price volatility. The value of the holdings of the Trust is reported on the Trust’s website, www.invesco.com/etfs, each business day.  

Definition of Net Asset Value

The Trustee calculates, and the Sponsor publishes, the Trust’s Net Asset Value (“NAV”) each business day. To calculate the NAV, the Trustee adds to the amount of Swiss Francs in the Trust at the end of the preceding day accrued but unpaid interest, if any, Swiss Francs receivable under pending purchase orders and the value of other Trust assets, and subtracts the accrued but unpaid Sponsor’s fee, Swiss Francs payable under pending redemption orders and other Trust expenses and liabilities, if any. The NAV is expressed in USD based on the Swiss Francs/USD exchange rate as determined by The WM Company at 4:00 PM (London time / London fixing) (the “Closing Spot Rate”) on each day that NYSE Arca is open for regular trading. If, on a particular evaluation day, the Closing Spot Rate has not been determined and announced by 6:00 PM (London time), then the most recent Closing Spot Rate is used to determine the NAV of the Trust unless the Trustee, in consultation with the Sponsor, determines that such price is inappropriate to use as the basis for the valuation.

The Trustee also determines the NAV per Share, which equals the NAV of the Trust divided by the number of outstanding Shares. The NAV of the Trust and the NAV per Share are published by the Sponsor on each day that NYSE Arca is open for regular trading and are posted on the Trust’s website, www.invesco.com/etfs.


12


Movements in the Price of the Swiss Franc

The investment objective of the Trust is for the Shares to reflect the price in USD of the Swiss Franc plus accrued interest, if any, less the expenses of the Trust’s operations. The Shares are intended to provide institutional and retail investors with a simple, cost-effective means of gaining investment benefits similar to those of holding Swiss Francs. Each outstanding Share represents a proportional interest in the Swiss Francs held by the Trust. The following chart provides recent trends on the price of the Swiss Franc. The chart illustrates movements in the price of the Swiss Franc in USD and is based on the Closing Spot Rate:

 

 

 

NAV per Share; Valuation of the Swiss Franc

The following chart illustrates the movement in the price of the Shares based on (1) NAV per Share, (2) the “bid” and “ask” midpoint offered on NYSE Arca and (3) the Closing Spot Rate, expressed as a multiple of 100 Swiss Francs:

 

 

13


Liquidity

The Sponsor is not aware of any trends, demands, conditions or events that are reasonably likely to result in material changes to the Trust’s liquidity needs. The Trust’s Depository, JPMorgan Chase Bank, N.A., London Branch, maintains two deposit accounts for the Trust, a primary deposit account that may earn interest and a secondary deposit account that does not earn interest. Interest on the primary deposit account, if any, accrues daily and is paid monthly. The interest rate in effect as of March 31, 2019 was an annual nominal rate of -0.75%. The following chart provides the daily rate paid by the Depository since March 31, 2014:

 

In exchange for a fee, the Sponsor bears most of the expenses incurred by the Trust. As a result, the only ordinary expense of the Trust during the period covered by this report was the Sponsor’s fee. Each month the Depository deposits into the secondary deposit account accrued but unpaid interest, if any, and the Trustee withdraws Swiss Franc from the secondary deposit account to pay the accrued Sponsor’s fee for the previous month plus other Trust expenses (including, without limitation, expenses resulting from negative interest rates) , if any. When the interest deposited, if any, exceeds the sum of the Sponsor’s fee for the prior month plus other Trust expenses, if any, the Trustee converts the excess into USD at the prevailing market rate and distributes the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own). The Trust did not make any distributions during the quarter ended March 31, 2019.

Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Sponsor’s management to make estimates and assumptions that affect the reported amounts of the assets and liabilities and disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period covered by this report.

In addition to the description below, please refer to Note 3 to the financial statements for further discussion of our accounting policies.

The functional currency of the Trust is the Swiss Franc in accordance with ASC 830, Foreign Currency Translation.

Results of Operations

As of December 31, 2018, the number of Swiss Francs owned by the Trust was 172,708,450, resulting in a redeemable capital Share value of $175,017,674. During the three months ended March 31, 2019, an additional 100,000 Shares were created in exchange for 9,312,870 Swiss Francs and 350,000 Shares were redeemed in exchange for 32,604,681 Swiss Francs. In addition, 478,390 Swiss Francs were withdrawn to pay the portion of the Sponsor’s fee that exceeded the interest earned. As of March 31, 2019, the number of Swiss Francs owned by the Trust was 148,938,249, resulting in a redeemable capital Share value of $149,403,443.

14


A decrease in the Trust’s redeemable capital Share value from $175,017,674 at December 31, 2018 to $149,403,443 at March 31, 2019, was primarily the result of a decrease in the number of Shares outstanding from 1,850,000 at December 31, 2018 to 1,600,000 at March 31, 2019 coupled with a decrease in the Closing Spot Rate from 1.0144 at December 31, 2018 to 1.0041 at March 31, 2019.

No interest income was earned during the three months ended March 31, 2018 and the three months ended March 31, 2019, due to an annual nominal interest rate which remained at or below 0.00% through those periods, as set forth in the chart above.

The Sponsor’s fee accrues daily at an annual nominal rate of 0.40% of the Swiss Francs in the Trust. Due primarily to an increase in the weighted-average Swiss Franc in the Trust, the Sponsor’s fee increased from $152,959 for the three months ended March 31, 2018 to $155,227 for the three months ended March 31, 2019. Because the annual interest rate paid by the Depository remained below 0.00%, the Trust incurred interest expense. Due primarily to an increase in the weighted-average Swiss Franc in the Trust, interest expense increased from $290,510 for the three months ended March 31, 2018 to $295,940 for the three months ended March 31, 2019. The only expenses of the Trust during the three months ended March 31, 2019 were the Sponsor’s fee and interest expense.

The Trust’s net comprehensive income (loss) for the three months ended March 31, 2019 was $(451,167), due to the Sponsor’s fee of $155,227 and interest expense of $295,940 exceeding interest income of $0. The Trust’s net comprehensive income (loss) for the three months ended March 31, 2018 was $(443,469) due to the Sponsor’s fee of $152,959 and interest expense of $290,510 exceeding interest income of $0.

Cash dividends were not paid by the Trust during the three months ended March 31, 2018 and the three months ended March 31, 2019 as the Trust’s interest income did not exceed the Trust’s expenses during those periods.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Except as described above with respect to fluctuations in the Swiss Franc/USD exchange rate and changes in the nominal annual interest rate paid by the Depository on Swiss Francs held by the Trust, the Trust is not subject to market risk. The Trust does not hold securities and does not invest in derivative products.

Item 4. Controls and Procedures

Under the supervision and with the participation of the management of the Sponsor, including Daniel Draper, its Principal Executive Officer, and Kelli Gallegos, its Principal Financial and Accounting Officer, Investment Pools, the Trust carried out an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report, and, based upon that evaluation, Daniel Draper, the Principal Executive Officer of the Sponsor, and Kelli Gallegos, the Principal Financial and Accounting Officer, Investment Pools, of the Sponsor, concluded that the Trust's disclosure controls and procedures were effective to provide reasonable assurance that information the Trust is required to disclose in the reports that it files or submits with the Securities and Exchange Commission (the “SEC”) under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms, and to provide reasonable assurance that information required to be disclosed by the Trust in the reports that it files or submits under the Exchange Act is accumulated and communicated to management of the Sponsor, including its Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There has been no change in internal control over financial reporting (as defined in the Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the Trust's quarter ended March 31, 2019 that has materially affected, or is reasonably likely to materially affect, the Trust's internal control over financial reporting.

15


PART II – OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Current Discussions between the SEC and PricewaterhouseCoopers LLP regarding PricewaterhouseCoopers LLP's Independence Could Have Potentially Adverse Consequences for the Trust.

PricewaterhouseCoopers LLP informed the Trust that it has identified an issue related to its independence under Rule 2-01(c)(1)(ii)(A) of Regulation S-X (referred to as the Loan Rule). The Loan Rule prohibits accounting firms, such as PricewaterhouseCoopers LLP, from being deemed independent if they have certain financial relationships with their audit clients or certain affiliates of those clients. The Trust is required under various securities laws to have its financial statements audited by an independent accounting firm.

The Loan Rule specifically provides that an accounting firm would not be independent if it or certain affiliates and covered persons receives a loan from a lender that is a record or beneficial owner of more than ten percent of an audit client’s equity securities (referred to as a “more than ten percent owner”). For purposes of the Loan Rule, audit clients include the Trust as well as all registered investment companies advised by the Sponsor and its affiliates, including other subsidiaries of the Sponsor’s parent company, Invesco Ltd. (collectively, the “Invesco Fund Complex”). PricewaterhouseCoopers LLP informed the Trust it and certain affiliates and covered persons have relationships with lenders who hold, as record owner, more than ten percent of the shares of certain funds within the Invesco Fund Complex, which may implicate the Loan Rule.

On June 20, 2016, the SEC Staff issued a “no-action” letter to another mutual fund complex (see Fidelity Management & Research Company et al., No-Action Letter) related to the audit independence issue described above. In that letter, the SEC confirmed that it would not recommend enforcement action against a fund that relied on audit services performed by an audit firm that was not in compliance with the Loan Rule in certain specified circumstances. On May 2, 2018, the SEC proposed amendments to the Loan Rule that, if adopted as proposed, would address many of the issues that led to issuance of the no-action letter. In connection with prior independence determinations, PricewaterhouseCoopers LLP communicated, as contemplated by the no-action letter, that it believes that it remains objective and impartial and that a reasonable investor possessing all the facts would conclude that PricewaterhouseCoopers LLP is able to exhibit the requisite objectivity and impartiality to report on the Trust’s financial statements as the independent registered public accounting firm. PricewaterhouseCoopers LLP also represented that it has complied with PCAOB Rule 3526(b)(1) and (2), which are conditions to the Trust relying on the no-action letter, and affirmed that it is an independent accountant within the meaning of PCAOB Rule 3520. Therefore, the Sponsor, the Trust and PricewaterhouseCoopers LLP concluded that PricewaterhouseCoopers LLP could continue as the Trust’s independent registered public accounting firm. The Invesco Fund Complex relied upon the no-action letter in reaching this conclusion.

If in the future the independence of PricewaterhouseCoopers LLP is called into question under the Loan Rule by circumstances that are not addressed in the SEC’s no-action letter, the Trust will need to take other action in order for the Trust’s filings with the SEC containing financial statements to be deemed compliant with applicable securities laws. Such additional actions could result in additional costs, impair the ability of the Trust to issue new shares or have other material adverse effects on the Trust. The SEC no-action relief was initially set to expire 18 months from issuance but has been extended by the SEC without an expiration date, except that the no-action letter will be withdrawn upon the effectiveness of any amendments to the Loan Rule designed to address the concerns expressed in the letter.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a) None.

(b) Not applicable.

(c) During the quarter ended March 31, 2019, 7 Baskets (350,000 Shares registered pursuant to Section 12 of the Securities Exchange Act of 1934) were redeemed by the Trust, as follows:

Period

 

Total Number

of Registered

Shares

Redeemed

 

 

Average Price

Per Share

 

01/01/2019 – 01/31/2019

 

 

100,000

 

 

$

94.36

 

02/01/2019 – 02/28/2019

 

 

200,000

 

 

$

93.72

 

03/01/2019 – 03/31/2019

 

 

50,000

 

 

$

93.73

 

Total

 

 

350,000

 

 

$

93.90

 

Item 3. Defaults Upon Senior Securities

None.

16


Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

17


Item 6. Exhibits

 Exhibit

No.

Description

 

 

  3.1

Certificate of Formation of the Sponsor dated September 14, 2005, incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form S-1/A (File number 333 132364) filed by the Trust on June 9, 2006.

 

 

  3.2

Certificate of Amendment to Certificate of Formation of the Sponsor dated March 27, 2012, incorporated herein by reference to Exhibit 3.2 to the Annual Report on Form 10-K filed by the Trust on January 14, 2013.

 

 

  3.3

Certificate of Amendment to the Certificate of Formation of the Sponsor dated April 6, 2018, incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the Trust on April 9, 2018.

 

 

  3.4

Third Amended and Restated Limited Liability Company Agreement of the Sponsor, incorporated herein by reference to Exhibit 3.2 to the Current Report on Form 8-K filed by the Trust on April 9, 2018.

 

 

  4.1

Depositary Trust Agreement dated as of June 8, 2006 among the Sponsor, The Bank of New York Mellon, all registered owners and beneficial owners of Swiss Franc Shares issued thereunder and all depositors, incorporated herein by reference to Exhibit 4.1 to the Annual Report on Form 10-K/A filed by the Trust on March 10, 2011.

 

 

  4.2

Amendment to Depositary Trust Agreement dated as of November 13, 2008 between the Sponsor and The Bank of New York Mellon, incorporated herein by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q filed by the Trust on September 9, 2010.

 

 

  4.3

Global Amendment to Depositary Trust Agreements dated as of March 6, 2012 between the Sponsor and The Bank of New York Mellon, incorporated herein by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q filed by the Trust on March 12, 2012.

 

 

  4.4

Global Amendment to Depositary Trust Agreements dated as of September 5, 2017 between the Sponsor and The Bank of New York Mellon, incorporated herein by reference to Exhibit 4.7 to the Quarterly Report on Form 10-Q filed by the Trust on September 11, 2017.

 

 

  4.5

Global Amendment to Depositary Trust Agreements dated as of June 4, 2018 between the Sponsor and The Bank of New York Mellon, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the Trust on June 4, 2018.

 

 

  4.6

Global Amendment to Depositary Trust Agreements dated as of January 9, 2019 between the Sponsor and The Bank of New York Mellon, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the Trust on January 11, 2019.

 

 

  4.7

Form of Participant Agreement among The Bank of New York Mellon, the Sponsor, and the Authorized Participants (listed in the Schedule attached thereto pursuant to Instruction 2 to Item 601 of Regulation S-K), incorporated herein by reference to Exhibit 4.6 to the Annual Report on Form 10-K filed by the Trust on January 11, 2019.

 

 

10.1

Deposit Account Agreement dated as of June 8, 2006 between The Bank of New York Mellon and the London Branch of JPMorgan Chase Bank, N.A., incorporated herein by reference to Exhibit 10.1 to the Annual Report on Form 10-K/A filed by the Trust on March 10, 2011.

 

 

10.2

Amendment to Deposit Account Agreement dated as of November 13, 2008 between The Bank of New York Mellon and the London Branch of JPMorgan Chase Bank, N.A., incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q filed by the Trust on September 9, 2010.

 

 

10.3

Amendment 2 to Deposit Account Agreement dated as of September 1, 2010 between The Bank of New York Mellon and the London Branch of JPMorgan Chase Bank, N.A., incorporated herein by reference to Exhibit 10.3 to the Annual Report on Form 10-K/A filed by the Trust on March 10, 2011.

 

 

10.4

Amendment 3 to Deposit Account Agreement dated as of August 10, 2011 between The Bank of New York Mellon and the London Branch of JPMorgan Chase Bank, N.A, incorporated herein by reference to Exhibit 10.4 to the Registration on Form S-3 (File No. 333-176370) filed by the Trust on August 17, 2011.

 

 

10.5

License Agreement dated as of April 6, 2018 between The Bank of New York Mellon and the Sponsor, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Trust on April 9, 2018.

 

 


18


31.1

Certification by Principal Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.

 

 

31.2

Certification by Principal Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.

 

 

32.1

Certification by Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

32.2

Certification by Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101.INS

XBRL Instance Document.

 

 

101.SCH

XBRL Taxonomy Extension Schema Document.

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

 

 

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

 

19


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

INVESCO CURRENCYSHARES®

SWISS FRANC TRUST

By:

Invesco Specialized Products, LLC

 

Sponsor of the Invesco CurrencyShares®

 

Swiss Franc Trust

 

Date: May 8, 2019

By:

/s/ Daniel Draper

 

 

Daniel Draper

 

 

Chief Executive Officer

 

 

(principal executive officer)

 

By:

/s/ Kelli Gallegos

 

Kelli Gallegos

 

Principal Financial and Accounting

 

Officer – Investment Pools

 

 

20

EX-31.1 2 fxf-ex311_9.htm EX-31.1 fxf-ex311_9.htm

 

EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302(A)

OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel Draper, certify that:

1. I have reviewed the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2019 of Invesco CurrencyShares® Swiss Franc Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves persons who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2019

 

/s/ Daniel Draper

Daniel Draper

Chief Executive Officer

(principal executive officer)

 

 

EX-31.2 3 fxf-ex312_8.htm EX-31.2 fxf-ex312_8.htm

 

EXHIBIT 31.2

CERTIFICATION PURSUANT TO SECTION 302(A)

OF THE SARBANES-OXLEY ACT OF 2002

I, Kelli Gallegos, certify that:

1. I have reviewed the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2019 of Invesco CurrencyShares® Swiss Franc Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves persons who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2019

 

/s/ Kelli Gallegos

Kelli Gallegos

Principal Financial and Accounting

Officer – Investment Pools

 

 

EX-32.1 4 fxf-ex321_7.htm EX-32.1 fxf-ex321_7.htm

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Invesco CurrencyShares® Swiss Franc Trust (the “Trust”) on Form 10-Q for the quarterly period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel Draper, Chief Executive Officer of Invesco Specialized Products, LLC, the Sponsor of the Trust, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.

Date: May 8, 2019

 

/s/ Daniel Draper

Daniel Draper*

Chief Executive Officer

(principal executive officer)

 

*

The Registrant is a trust and Daniel Draper is signing in his capacity as the principal executive officer of Invesco Specialized Products, LLC, the Sponsor of the Registrant.

 

 

EX-32.2 5 fxf-ex322_6.htm EX-32.2 fxf-ex322_6.htm

 

EXHIBIT 32.2

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Invesco CurrencyShares® Swiss Franc Trust (the “Trust”) on Form 10-Q for the quarterly period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kelli Gallegos, Principal Financial and Accounting Officer – Investment Pools of Invesco Specialized Products, LLC, the Sponsor of the Trust, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.

Date: May 8, 2019

 

/s/ Kelli Gallegos

Kelli Gallegos*

Principal Financial and Accounting

Officer – Investment Pools

 

*

The Registrant is a trust and Kelli Gallegos is signing in her capacity as the principal financial officer of Invesco Specialized Products, LLC, the Sponsor of the Registrant.

 

 

GRAPHIC 6 g4spkqrpp3ef000001.jpg GRAPHIC begin 644 g4spkqrpp3ef000001.jpg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end GRAPHIC 7 g4spkqrpp3ef000003.jpg GRAPHIC begin 644 g4spkqrpp3ef000003.jpg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end GRAPHIC 8 g4spkqrpp3ef000002.jpg GRAPHIC begin 644 g4spkqrpp3ef000002.jpg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end EX-101.INS 9 fxf-20190331.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:CHF fxf:Depositor xbrli:pure 0001353615 2019-01-01 2019-03-31 0001353615 2019-03-31 0001353615 2018-12-31 0001353615 2018-01-01 2018-03-31 0001353615 fxf:RedeemableCapitalSharesMember 2018-12-31 0001353615 fxf:RedeemableCapitalSharesMember 2019-01-01 2019-03-31 0001353615 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001353615 fxf:RedeemableCapitalSharesMember 2019-03-31 0001353615 fxf:RedeemableCapitalSharesMember 2017-12-31 0001353615 fxf:RedeemableCapitalSharesMember 2018-01-01 2018-03-31 0001353615 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001353615 fxf:RedeemableCapitalSharesMember 2018-03-31 0001353615 2017-12-31 0001353615 2018-03-31 0001353615 2006-06-08 0001353615 2018-11-01 2018-12-31 0001353615 fxf:SponsorMember fxf:AccruedProfessionalFeesMember 2019-01-01 2019-03-31 0001353615 fxf:SponsorMember fxf:ProfessionalFeesLiabilityMember 2019-01-01 2019-03-31 10-Q false 2019-03-31 2019 Q1 FXF Invesco CurrencyShares Swiss Franc Trust 0001353615 --12-31 Accelerated Filer true false 1600000 149551411 175196237 0 0 149551411 175196237 50885 61461 97083 117102 147968 178563 149403443 175017674 0 0 149551411 175196237 29500000 29500000 1600000 1850000 1600000 1850000 0 0 0 0 155227 152959 295940 290510 451167 443469 -451167 -443469 -0.27 -0.28 1678889 1562222 175017674 9316175 32867039 -23550864 -451167 451167 451167 -451167 -1612200 149403443 150066823 9922904 9922904 -443469 443469 443469 -443469 2557350 162103608 0 0 -20019 3062 -10576 1828 -481762 -438579 0 0 9316175 9922904 32867039 0 -23550864 9922904 -1612200 2557350 -25644826 12041675 175196237 150214855 149551411 162256530 <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-weight:bold;">1.</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="BACKGROUND"></a><a name="BACKGROUND"></a>Background </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September&#160;28, 2017, Guggenheim Capital, LLC (&#8220;Guggenheim&#8221;) and Invesco Ltd. entered into a Transaction Agreement (the &#8220;Transaction Agreement&#8221;), pursuant to which Guggenheim agreed to transfer all of the membership interests of Guggenheim Specialized Products, LLC (the &#8220;Sponsor&#8221;) to Invesco Capital Management LLC (&#8220;Invesco Capital Management&#8221;). </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Transaction Agreement was consummated on April&#160;6, 2018 (the &#8220;Closing&#8221;) and immediately following the Closing, Invesco Capital Management changed the name of the Sponsor to Invesco Specialized Products, LLC. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January&#160;9, 2019, the Sponsor changed the Trust&#8217;s fiscal year from the period beginning on November&#160;1 and ending on October&#160;31 to the period beginning on January&#160;1 and ending on December 31. Unless otherwise noted, all references to &#8220;years&#8221; in this report refer to the twelve-month fiscal year, which prior to November&#160;1, 2018 ended on October&#160;31 and beginning after December&#160;31, 2018 ends on December&#160;31 of each year. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><a name="N2_ORGANIZATION_DESCRIPTION__TRUST"></a><a name="N2_ORGANIZATION_DESCRIPTION__TRUST"></a>Organization and Description of the Trust </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Invesco CurrencyShares<sup style="font-size:85%; vertical-align:top">&#174;</sup> Swiss Franc Trust (the &#8220;Trust&#8221;) was formed under the laws of the State of New York on June&#160;8, 2006 when the Sponsor deposited 100 Swiss Francs in the Trust&#8217;s primary deposit account held by JPMorgan Chase Bank, N.A., London Branch (the &#8220;Depository&#8221;). The Sponsor is a Delaware limited liability company whose sole member is Invesco Capital Management. The Sponsor is responsible for, among other things, overseeing the performance of The Bank of New York Mellon (the &#8220;Trustee&#8221;) and the Trust&#8217;s principal service providers, including the preparation of financial statements. The Trustee is responsible for the day-to-day administration of the Trust. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The investment objective of the Trust is for the Trust&#8217;s shares (the &#8220;Shares&#8221;) to reflect the price in U.S. Dollars (&#8220;USD&#8221;) of the Swiss Franc plus accrued interest, if any, less the Trust&#8217;s expenses and liabilities. The Shares are intended to provide investors with a simple, cost-effective means of gaining investment benefits similar to those of holding Swiss Francs. The Trust&#8217;s assets primarily consist of Swiss Francs on demand deposit in two deposit accounts maintained by the Depository: a primary deposit account which may earn interest and a secondary deposit account which does not earn interest. The secondary deposit account is used to account for any interest that may be received and paid out on creations and redemptions of blocks of 50,000 Shares (&#8220;Baskets&#8221;). The secondary account is also used to account for interest earned, if any, on the primary deposit account, pay Trust expenses and distribute any excess interest to holders of Shares (&#8220;Shareholders&#8221;) on a monthly basis. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission. In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period. These financial statements and the notes thereto should be read in conjunction with the Trust&#8217;s financial statements included in the Form 10-K transition report as filed on March 11, 2019.</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><a name="N3_SIGNIFICANT_ACCOUNTING_POLICIES"></a><a name="N3_SIGNIFICANT_ACCOUNTING_POLICIES"></a>Significant Accounting Policies </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Use of Estimates </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets, liabilities and disclosures of contingent liabilities at the date of the financial statements, the reported amounts of revenue and expenses during the period and the evaluation of subsequent events through the issuance date of the financial statements. Actual results could differ from those estimates. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Foreign Currency Translation </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For Net Asset Value (&#8220;NAV&#8221;) calculation purposes, Swiss Franc deposits (cash) are translated at the Closing Spot Rate, which is the Swiss Franc/USD exchange rate as determined and published by The WM Company at 4:00 PM (London time / London fixing) on each day that NYSE Arca, Inc. (&#8220;NYSE Arca&#8221;) is open for regular trading. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust maintains its books and records in Swiss Francs. For financial statement reporting purposes, the U.S.&#160;Dollar is the reporting currency. As a result, the financial records of the Trust are translated from Swiss Francs to USD. The Closing Spot Rate on the last day of the period is used for translation in the statements of financial condition. The average Closing Spot Rate for the period is used for translation in the statements of comprehensive income and the statements of cash flows. The redeemable capital Shares are adjusted to redemption value and these adjustments are recorded against retained earnings. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">C.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Federal Income Taxes </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust is treated as a &#8220;grantor trust&#8221; for federal income tax purposes and, therefore, no provision for federal income taxes is required. Interest, gains and losses are passed through to the Shareholders. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shareholders generally will be treated, for U.S. federal income tax purposes, as if they directly owned a pro-rata share of the assets held in the Trust. Shareholders also will be treated as if they directly received their respective pro-rata portion of the Trust&#8217;s income, if any, and as if they directly incurred their respective pro-rata portion of the Trust&#8217;s expenses. The acquisition of Shares by a U.S. Shareholder as part of a creation of a Basket will not be a taxable event to the Shareholder. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Sponsor&#8217;s fee accrues daily and is payable monthly. For U.S. federal income tax purposes, an accrual-basis U.S. Shareholder generally will be required to take into account as an expense its allocable portion of the USD-equivalent of the amount of the Sponsor&#8217;s fee that is accrued on each day, with such USD-equivalent being determined by the currency exchange rate that is in effect on the respective day. To the extent that the currency exchange rate on the date of payment of the accrued amount of the Sponsor&#8217;s fee differs from the currency exchange rate in effect on the day of accrual, the U.S. Shareholder will recognize a currency gain or loss for U.S. federal income tax purposes. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust does not expect to generate taxable income except for interest income (if any) and gain (if any) upon the sale of Swiss Francs. A non-U.S. Shareholder generally will not be subject to U.S. federal income tax with respect to gain recognized upon the sale or other disposition of Shares, or upon the sale of Swiss Francs by the Trust, unless: (1)&#160;the non-U.S. Shareholder is an individual and is present in the United States for 183 days or more during the taxable year of the sale or other disposition, and the gain is treated as being from United States sources; or (2)&#160;the gain is effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A non-U.S. Shareholder&#8217;s portion of any interest income earned by the Trust generally will not be subject to U.S. federal income tax unless the Shares owned by such non-U.S. Shareholder are effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">D.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Revenue Recognition </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on the primary deposit account, if any, accrues daily as earned and is received or paid on a monthly basis. Any interest below zero for the period is reflected as interest expense on currency deposits. The Depository may change the rate at which interest accrues, including reducing the interest rate to zero or below zero, based upon changes in market conditions or based on the Depository&#8217;s liquidity needs. Interest charged on the primary deposit account will be disclosed as interest expense on currency deposits. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">E.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Dividends </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the interest earned by the Trust, if any, exceeds the sum of the Sponsor&#8217;s fee for the prior month plus other Trust expenses, if any, the Trust will distribute, as a dividend (herein referred to as dividends or distributions), the excess interest earned in Swiss Francs effective on the first business day of the subsequent month. The Trustee will direct that the excess Swiss Francs be converted into USD at the prevailing market rate and the Trustee will distribute the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own). </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><a name="N4_SWISS_FRANC_DEPOSITS"></a><a name="N4_SWISS_FRANC_DEPOSITS"></a>Swiss Franc Deposits </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Swiss Franc principal deposits are held in a Swiss Franc-denominated, interest-bearing demand account. The interest rate in effect as of March&#160;31, 2019 was an annual nominal rate of -0.75%. For the three months ended March&#160;31, 2019, there were Swiss Franc principal deposits of 9,312,870, Swiss Franc principal redemptions of 32,604,681 and Swiss Franc withdrawals (to pay expenses) of 478,390, resulting in an ending Swiss Franc principal balance of 148,938,249. This equates to 149,551,411 USD. For the two months ended December&#160;31, 2018, there were Swiss Franc principal deposits of 18,683,840, Swiss Franc principal redemptions of 23,343,201 and Swiss Franc withdrawals (to pay expenses) of 345,547, resulting in an ending Swiss Franc principal balance of 172,708,450. This equates to 175,196,237 USD.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net interest, if any, associated with creation and redemption activity is held in a Swiss Franc-denominated non-interest-bearing account, and any balance is distributed in full as part of the monthly income distributions, if any. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="N5_REDEEMABLE_CAPITAL_SHARES"></a><a name="N5_REDEEMABLE_CAPITAL_SHARES"></a>5. Redeemable Capital Shares </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares are classified as &#8220;redeemable&#8221; for financial statement purposes, since they are subject to redemption. Shares are issued and redeemed continuously in Baskets in exchange for Swiss Francs. Individual investors cannot purchase or redeem Shares in direct transactions with the Trust. Only Authorized Participants (as defined below) may place orders to create and redeem Baskets. An Authorized Participant is a Depository Trust Company (&#8220;DTC&#8221;) participant that is a registered broker-dealer or other institution eligible to settle securities transactions through the book-entry facilities of the DTC and which has entered into a contractual arrangement with the Trust and the Sponsor governing, among other matters, the creation and redemption process. Authorized Participants may redeem their Shares at any time in Baskets. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to expected continuing creations and redemptions of Baskets and the two-day period for settlement of each creation or redemption, the Trust reflects Shares created as a receivable on the trade date. Shares redeemed are reflected as a liability on the trade date. Outstanding Shares are reflected at a redemption value, which is the NAV per Share at the period end date. Adjustments to redeemable capital Shares at redemption value are recorded directly to redeemable capital shares and retained earnings. </p> <p style="margin-bottom:6pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Activity in redeemable capital Shares is as follows: </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.08%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March&#160;31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="8" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.7%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31, 2018</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">U.S. Dollar</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">U.S. Dollar</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Opening Balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,850,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175,017,674</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,550,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,066,823</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,316,175</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,922,904</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares redeemed</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(350,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,867,039</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment of Redeemable Capital Shares to Redemption Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,063,367</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,113,881</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,600,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,403,443</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,650,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,103,608</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trustee calculates the Trust&#8217;s NAV each business day. To calculate the NAV, the Trustee subtracts the Sponsor&#8217;s accrued fee through the previous day from the Swiss Francs held by the Trust (including all unpaid interest, if any, accrued through the preceding day) and calculates the value of the Swiss Francs in USD based upon the Closing Spot Rate. If, on a particular evaluation day, the Closing Spot Rate has not been determined and announced by 6:00 PM (London time), then the most recent Closing Spot Rate will be used to determine the NAV of the Trust unless the Trustee, in consultation with the Sponsor, determines that such price is inappropriate to use as the basis for the valuation. If the Trustee and the Sponsor determine that the most recent Closing Spot Rate is not an appropriate basis for valuation of the Trust&#8217;s Swiss Francs, they will determine an alternative basis for the valuation. The Trustee also determines the NAV per Share, which equals the NAV of the Trust, divided by the number of outstanding Shares. Shares deliverable under a purchase order are considered outstanding for purposes of determining NAV per Share; Shares deliverable under a redemption order are not considered outstanding for this purpose. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="N7_RELATED_PARTIES"></a>6.<font style="font-weight:normal;margin-left:36pt;"></font><a name="N7_RELATED_PARTIES"></a>Related Parties </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Sponsor is a related party of the Trust. The Sponsor&#8217;s fee accrues daily at an annual nominal rate of 0.40% of the Swiss Francs in the Trust (including all unpaid interest but excluding unpaid fees, each as accrued through the immediately preceding day) and is paid monthly. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Sponsor assumes and pays the following administrative and marketing expenses incurred by the Trust: the Trustee&#8217;s monthly fee, NYSE Arca listing fees, SEC registration fees, typical maintenance and transaction fees of the Depository, printing and mailing costs, audit fees and expenses, up to $100,000 per year in legal fees and expenses, and applicable license fees. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain exceptional cases the Trust will pay for some expenses in addition to the Sponsor&#8217;s fee. These exceptions include expenses not assumed by the Sponsor (i.e., expenses other than those identified in the preceding paragraph), expenses resulting from negative interest rates, taxes and governmental charges, expenses and costs of any extraordinary services performed by the Trustee or the Sponsor on behalf of the Trust or action taken by the Trustee or the Sponsor to protect the Trust or the interests of Shareholders, indemnification of the Sponsor under the Depositary Trust Agreement, audit fees and legal expenses in excess of $100,000 per year. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><a name="N8_CONCENTRATION_RISK"></a><font style="font-weight:normal;"></font><a name="N8_CONCENTRATION_RISK"></a>Concentration Risk </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of the Trust&#8217;s assets are Swiss Francs, which creates a concentration risk associated with fluctuations in the price of the Swiss Franc. Accordingly, a decline in the Swiss Franc to USD exchange rate will have an adverse effect on the value of the Shares. Factors that may have the effect of causing a decline in the price of the Swiss Franc include national debt levels and trade deficits, domestic and foreign inflation rates, domestic and foreign interest rates, investment and trading activities of institutions and global or regional political, economic or financial events and situations. Substantial sales of Swiss Francs by the official sector (central banks, other governmental agencies and related institutions that buy, sell and hold Swiss Francs as part of their reserve assets) could adversely affect an investment in the Shares. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of the Trust&#8217;s Swiss Francs are held by the Depository. Accordingly, a risk associated with the concentration of the Trust&#8217;s assets in accounts held by a single financial institution exists and increases the potential for loss by the Trust and the Trust&#8217;s beneficiaries in the event that the Depository becomes insolvent. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><a name="N9_COMMITMENTS_CONTINGENCIES"></a><font style="font-weight:normal;"></font><a name="N9_COMMITMENTS_CONTINGENCIES"></a>Commitments and Contingencies </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust&#8217;s organizational documents provide for the Trust to indemnify the Sponsor and any affiliate of the Sponsor that provides services to the Trust to the maximum extent permitted by applicable law, subject to certain exceptions for disqualifying conduct by the Sponsor or such an affiliate. The Trust&#8217;s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Trust that have not yet occurred. Further, the Trust has not had prior claims or losses pursuant to these contracts. Accordingly, the Sponsor expects the risk of loss to be remote. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Use of Estimates </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets, liabilities and disclosures of contingent liabilities at the date of the financial statements, the reported amounts of revenue and expenses during the period and the evaluation of subsequent events through the issuance date of the financial statements. Actual results could differ from those estimates. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Foreign Currency Translation </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For Net Asset Value (&#8220;NAV&#8221;) calculation purposes, Swiss Franc deposits (cash) are translated at the Closing Spot Rate, which is the Swiss Franc/USD exchange rate as determined and published by The WM Company at 4:00 PM (London time / London fixing) on each day that NYSE Arca, Inc. (&#8220;NYSE Arca&#8221;) is open for regular trading. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust maintains its books and records in Swiss Francs. For financial statement reporting purposes, the U.S.&#160;Dollar is the reporting currency. As a result, the financial records of the Trust are translated from Swiss Francs to USD. The Closing Spot Rate on the last day of the period is used for translation in the statements of financial condition. The average Closing Spot Rate for the period is used for translation in the statements of comprehensive income and the statements of cash flows. The redeemable capital Shares are adjusted to redemption value and these adjustments are recorded against retained earnings. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">C.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Federal Income Taxes </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust is treated as a &#8220;grantor trust&#8221; for federal income tax purposes and, therefore, no provision for federal income taxes is required. Interest, gains and losses are passed through to the Shareholders. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shareholders generally will be treated, for U.S. federal income tax purposes, as if they directly owned a pro-rata share of the assets held in the Trust. Shareholders also will be treated as if they directly received their respective pro-rata portion of the Trust&#8217;s income, if any, and as if they directly incurred their respective pro-rata portion of the Trust&#8217;s expenses. The acquisition of Shares by a U.S. Shareholder as part of a creation of a Basket will not be a taxable event to the Shareholder. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Sponsor&#8217;s fee accrues daily and is payable monthly. For U.S. federal income tax purposes, an accrual-basis U.S. Shareholder generally will be required to take into account as an expense its allocable portion of the USD-equivalent of the amount of the Sponsor&#8217;s fee that is accrued on each day, with such USD-equivalent being determined by the currency exchange rate that is in effect on the respective day. To the extent that the currency exchange rate on the date of payment of the accrued amount of the Sponsor&#8217;s fee differs from the currency exchange rate in effect on the day of accrual, the U.S. Shareholder will recognize a currency gain or loss for U.S. federal income tax purposes. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Trust does not expect to generate taxable income except for interest income (if any) and gain (if any) upon the sale of Swiss Francs. A non-U.S. Shareholder generally will not be subject to U.S. federal income tax with respect to gain recognized upon the sale or other disposition of Shares, or upon the sale of Swiss Francs by the Trust, unless: (1)&#160;the non-U.S. Shareholder is an individual and is present in the United States for 183 days or more during the taxable year of the sale or other disposition, and the gain is treated as being from United States sources; or (2)&#160;the gain is effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A non-U.S. Shareholder&#8217;s portion of any interest income earned by the Trust generally will not be subject to U.S. federal income tax unless the Shares owned by such non-U.S. Shareholder are effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">D.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Revenue Recognition </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on the primary deposit account, if any, accrues daily as earned and is received or paid on a monthly basis. Any interest below zero for the period is reflected as interest expense on currency deposits. The Depository may change the rate at which interest accrues, including reducing the interest rate to zero or below zero, based upon changes in market conditions or based on the Depository&#8217;s liquidity needs. Interest charged on the primary deposit account will be disclosed as interest expense on currency deposits. </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">E.</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Dividends </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the interest earned by the Trust, if any, exceeds the sum of the Sponsor&#8217;s fee for the prior month plus other Trust expenses, if any, the Trust will distribute, as a dividend (herein referred to as dividends or distributions), the excess interest earned in Swiss Francs effective on the first business day of the subsequent month. The Trustee will direct that the excess Swiss Francs be converted into USD at the prevailing market rate and the Trustee will distribute the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own). </p> <p style="margin-bottom:6pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Activity in redeemable capital Shares is as follows: </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.08%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March&#160;31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="8" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.7%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31, 2018</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">U.S. Dollar</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">U.S. Dollar</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Opening Balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,850,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175,017,674</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,550,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,066,823</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,316,175</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,922,904</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares redeemed</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(350,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,867,039</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment of Redeemable Capital Shares to Redemption Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,063,367</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,113,881</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.44%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,600,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,403,443</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,650,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,103,608</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> 100 2006-06-08 2 50000 0 P183D 9312870 18683840 32604681 23343201 478390 345547 148938249 149551411 172708450 175196237 0.0075 P2D 1550000 150066823 100000 9316175 100000 9922904 350000 32867039 -2063367 2113881 1650000 162103608 0.0040 100000 100000 EX-101.SCH 10 fxf-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Statements of Financial Condition (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Statements of Financial Condition (Parenthetical) (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Statements of Comprehensive Income (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Statements of Changes in Shareholders' Equity and Redeemable Capital Shares (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Statements of Cash Flows (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Background link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Organization and Description of the Trust link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Swiss Franc Deposits link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Redeemable Capital Shares link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Related Parties link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Concentration Risk link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Redeemable Capital Shares (Tables) link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Organization and Description of the Trust - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Swiss Franc Deposits - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Redeemable Capital Shares - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Redeemable Capital Shares - Schedule for Redeemable Capital Shares Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Related Parties - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 11 fxf-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 fxf-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 fxf-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Document and entity information. Document And Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current Assets: Assets Current [Abstract] Swiss Franc deposits, interest bearing Interest Bearing Deposits In Banks Swiss Franc deposits, non-interest bearing Due From Banks Total Current Assets Assets Current Liabilities, Redeemable Capital Shares and Shareholders’ Equity Liabilities And Stockholders Equity [Abstract] Current Liabilities: Liabilities Current [Abstract] Accrued Sponsor’s fee Due To Related Parties Current Accrued interest expense on currency deposits Interest Payable Current Total Current Liabilities Liabilities Current Commitments and Contingent Liabilities (note 8) Commitments And Contingencies Redeemable Capital Shares, at redemption value, no par value, 29,500,000 authorized – 1,600,000 and 1,850,000 issued and outstanding, respectively Redeemable Noncontrolling Interest Equity Carrying Amount Shareholders’ Equity: Stockholders Equity [Abstract] Retained Earnings Retained Earnings Accumulated Deficit Total Liabilities, Redeemable Capital Shares and Shareholders’ Equity Liabilities And Stockholders Equity Redeemable Capital Shares,no par value Temporary Equity Par Or Stated Value Per Share Redeemable Capital Shares, shares authorized Temporary Equity Shares Authorized Redeemable Capital Shares, shares issued Temporary Equity Shares Issued Redeemable Capital Shares, shares outstanding Temporary Equity Shares Outstanding Statement Of Income And Comprehensive Income [Abstract] Income Revenues [Abstract] Interest Income Investment Income Interest Total Income Revenues Expenses Costs And Expenses [Abstract] Sponsor’s fee Sponsor Fees Interest Expense on currency deposits Interest Expense Total Expenses Operating Expenses Net Comprehensive Income (Loss) Net Income Loss Basic and Diluted Earnings per Share Earnings Per Share Basic And Diluted Weighted-average Shares Outstanding Weighted Average Number Of Share Outstanding Basic And Diluted Temporary Equity Stock Redeemed During Period Value New Issues Stockholders equity period increase decrease due to share transactions. Temporary equity period increase decrease due to share transactions. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Retained Earnings [Member] Retained Earnings [Member] Redeemable capital shares. Redeemable Capital Shares [Member] Redeemable Capital Shares [Member] Statement [Line Items] Statement [Line Items] Balance Stockholders Equity Including Portion Attributable To Noncontrolling Interest Balance Purchases of Shares Stock Issued During Period Value New Issues Purchases of Shares Temporary Equity Stock Issued During Period Value New Issues Redemption of Shares Stock Redeemed Or Called During Period Value Redemption of Shares Temporary Equity Stock Redeemed During Period Value New Issues Net Increase (Decrease) due to Share Transactions Stockholders Equity Period Increase Decrease Due To Share Transactions Net Increase (Decrease) due to Share Transactions Temporary Equity Period Increase Decrease Due To Share Transactions Distributions Partners Capital Account Distributions Net Comprehensive Income (Loss) Adjustment of Redeemable Capital Shares to Redemption Value related to Retained Earnings Reclassifications Of Temporary To Permanent Equity Adjustment of Redeemable Capital Shares to Redemption Value Temporary Equity Issue Period Increase Or Decrease Balance Increase decrease in accrued interest expense. Statement Of Cash Flows [Abstract] Cash flows from operating activities Net Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net comprehensive income (loss) to net cash provided by (used in) operating activities: Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Change in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Receivable from accrued interest Increase Decrease In Accrued Interest Receivable Net Accrued interest expense Increase Decrease In Accrued Interest Expense Accrued Sponsor's fee Increase Decrease In Due To Related Parties Current Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from financing activities Net Cash Provided By Used In Financing Activities [Abstract] Distributions paid to shareholders Distribution Made To Limited Partner Cash Distributions Paid Proceeds from purchases of redeemable Shares Proceeds From Issuance Of Redeemable Preferred Stock Redemptions of redeemable Shares Payments For Repurchase Of Redeemable Preferred Stock Net cash used in financing activities Net Cash Provided By Used In Financing Activities Effect of exchange rate on cash Effect Of Exchange Rate On Cash Net change in cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash at beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash at end of period Accounting Policies [Abstract] Background Business Description And Basis Of Presentation [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization and Description of the Trust Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Significant Accounting Policies Significant Accounting Policies [Text Block] Cash And Cash Equivalents [Abstract] Swiss Franc Deposits Cash And Cash Equivalents Disclosure [Text Block] Federal Home Loan Banks [Abstract] Redeemable Capital Shares Stockholders Equity Note Disclosure [Text Block] Related Party Transactions [Abstract] Related Parties Related Party Transactions Disclosure [Text Block] Risks And Uncertainties [Abstract] Concentration Risk Concentration Risk Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Use of Estimates Use Of Estimates Foreign Currency Translation Foreign Currency Transactions And Translations Policy [Text Block] Federal Income Taxes Income Tax Policy [Text Block] Revenue Recognition Revenue Recognition Policy [Text Block] The entire disclosure for dividends. Dividends Dividends Policy [Text Block] Schedule for Redeemable Capital Shares Activity Temporary Equity Table [Text Block] Initial incorporation deposit with bank sponsor. Initial deposits by Sponsor, Primary deposit account Initial Incorporation Deposit With Bank Sponsor Incorporation date Entity Incorporation Date Of Incorporation Number of deposits accounts in which trust assets primarily consist demand deposit. Stock redeemable number share each block shares. Number of deposits accounts in which trust's assets primarily consist of Swiss Francs Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit Redemptions Capital Shares, Number of shares in each Block Stock Redeemable In Baskets Number Of Shares Provision for federal income taxes Income Tax Expense Benefit Minimum period require to stay for tax liability. Number of days residing in country for income tax purpose Minimum Period Required To Stay For Tax Liability Principal deposits Principal redemptions Withdrawals (to pay expenses) Payments For Operating Activities Deposits, interest bearing Cash Annual nominal rate Investment Interest Rate Redeemable capital shares settlement period creation and redemption. Temporary Equity Disclosure [Abstract] Redeemable capital shares settlement period creation and redemption Redeemable Capital Shares Settlement Period Creation And Redemption Temporary Equity Shares Issued During Period Temporary Equity Shares Redeemed During Period Opening Balance, Shares Shares issued, Shares Temporary Equity Shares Issued During Period Shares redeemed, Shares Temporary Equity Shares Redeemed During Period Ending Balance, Shares Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Related Party Transactions By Related Party [Axis] Related Party Related Party [Domain] Sponsor [Member] Sponsor [Member] Sponsor [Member] Related Party Transaction Related Party Transaction [Axis] Related Party Transaction Related Party Transaction [Domain] Accrued Professional Fees [Member] Accrued Professional Fees [Member] Accrued Professional Fees [Member] Professional Fees Liability [Member] Professional Fees Liability [Member] Professional Fees Liability [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Sponsor's fee accrues daily and paid monthly, annual nominal Rate Related Party Transaction Rate Legal fees and expenses assumed sponsor. Legal fees and expenses assumed Maximum Threshold Annual Amount Of Payments Legal Fees And Expenses Represents the minimum threshold for legal fees and expenses. Excess amount of assumed audit fees and legal expenses Minimum Threshold Excess Annual Amount Of Payments Legal Fees And Expenses EX-101.PRE 14 fxf-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information
3 Months Ended
Mar. 31, 2019
shares
Document And Entity Information [Abstract]  
Document Type 10-Q
Amendment Flag false
Document Period End Date Mar. 31, 2019
Document Fiscal Year Focus 2019
Document Fiscal Period Focus Q1
Trading Symbol FXF
Entity Registrant Name Invesco CurrencyShares Swiss Franc Trust
Entity Central Index Key 0001353615
Current Fiscal Year End Date --12-31
Entity Filer Category Accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Common Stock, Shares Outstanding 1,600,000
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Financial Condition (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current Assets:    
Swiss Franc deposits, interest bearing $ 149,551,411 $ 175,196,237
Swiss Franc deposits, non-interest bearing 0 0
Total Current Assets 149,551,411 175,196,237
Current Liabilities:    
Accrued Sponsor’s fee 50,885 61,461
Accrued interest expense on currency deposits 97,083 117,102
Total Current Liabilities 147,968 178,563
Commitments and Contingent Liabilities (note 8)
Redeemable Capital Shares, at redemption value, no par value, 29,500,000 authorized – 1,600,000 and 1,850,000 issued and outstanding, respectively 149,403,443 175,017,674
Shareholders’ Equity:    
Retained Earnings 0 0
Total Liabilities, Redeemable Capital Shares and Shareholders’ Equity $ 149,551,411 $ 175,196,237
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Financial Condition (Parenthetical) (Unaudited) - $ / shares
Mar. 31, 2019
Dec. 31, 2018
Statement Of Financial Position [Abstract]    
Redeemable Capital Shares,no par value
Redeemable Capital Shares, shares authorized 29,500,000 29,500,000
Redeemable Capital Shares, shares issued 1,600,000 1,850,000
Redeemable Capital Shares, shares outstanding 1,600,000 1,850,000
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Comprehensive Income (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income    
Interest Income $ 0 $ 0
Total Income 0 0
Expenses    
Sponsor’s fee (155,227) (152,959)
Interest Expense on currency deposits (295,940) (290,510)
Total Expenses (451,167) (443,469)
Net Comprehensive Income (Loss) $ (451,167) $ (443,469)
Basic and Diluted Earnings per Share $ (0.27) $ (0.28)
Weighted-average Shares Outstanding 1,678,889 1,562,222
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Changes in Shareholders' Equity and Redeemable Capital Shares (Unaudited) - USD ($)
Total
Retained Earnings [Member]
Redeemable Capital Shares [Member]
Balance at Dec. 31, 2017 $ 150,066,823   $ 150,066,823
Purchases of Shares 9,922,904   9,922,904
Net Increase (Decrease) due to Share Transactions     9,922,904
Net Comprehensive Income (Loss) (443,469) $ (443,469)  
Adjustment of Redeemable Capital Shares to Redemption Value related to Retained Earnings 443,469 443,469 (443,469)
Adjustment of Redeemable Capital Shares to Redemption Value 2,113,881   2,557,350
Balance at Mar. 31, 2018 162,103,608   162,103,608
Balance at Dec. 31, 2018 175,017,674   175,017,674
Purchases of Shares 9,316,175   9,316,175
Redemption of Shares (32,867,039)   (32,867,039)
Net Increase (Decrease) due to Share Transactions     (23,550,864)
Net Comprehensive Income (Loss) (451,167) (451,167)  
Adjustment of Redeemable Capital Shares to Redemption Value related to Retained Earnings 451,167 $ 451,167 (451,167)
Adjustment of Redeemable Capital Shares to Redemption Value (2,063,367)   (1,612,200)
Balance at Mar. 31, 2019 $ 149,403,443   $ 149,403,443
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Cash Flows (Unaudited)
3 Months Ended
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Cash flows from operating activities    
Net Comprehensive Income (Loss) $ (451,167) $ (443,469)
Change in operating assets and liabilities:    
Receivable from accrued interest 0 0
Accrued interest expense (20,019) 3,062
Accrued Sponsor's fee (10,576) 1,828
Net cash used in operating activities (481,762) (438,579)
Cash flows from financing activities    
Distributions paid to shareholders 0 0
Proceeds from purchases of redeemable Shares 9,316,175 9,922,904
Redemptions of redeemable Shares (32,867,039) 0
Net cash used in financing activities (23,550,864) 9,922,904
Effect of exchange rate on cash (1,612,200) 2,557,350
Net change in cash (25,644,826) 12,041,675
Cash at beginning of period 175,196,237 150,214,855
Cash at end of period $ 149,551,411 $ 162,256,530
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Background
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Background

1.

Background

On September 28, 2017, Guggenheim Capital, LLC (“Guggenheim”) and Invesco Ltd. entered into a Transaction Agreement (the “Transaction Agreement”), pursuant to which Guggenheim agreed to transfer all of the membership interests of Guggenheim Specialized Products, LLC (the “Sponsor”) to Invesco Capital Management LLC (“Invesco Capital Management”).

The Transaction Agreement was consummated on April 6, 2018 (the “Closing”) and immediately following the Closing, Invesco Capital Management changed the name of the Sponsor to Invesco Specialized Products, LLC.

On January 9, 2019, the Sponsor changed the Trust’s fiscal year from the period beginning on November 1 and ending on October 31 to the period beginning on January 1 and ending on December 31. Unless otherwise noted, all references to “years” in this report refer to the twelve-month fiscal year, which prior to November 1, 2018 ended on October 31 and beginning after December 31, 2018 ends on December 31 of each year.

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Description of the Trust
3 Months Ended
Mar. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Organization and Description of the Trust

2.

Organization and Description of the Trust

The Invesco CurrencyShares® Swiss Franc Trust (the “Trust”) was formed under the laws of the State of New York on June 8, 2006 when the Sponsor deposited 100 Swiss Francs in the Trust’s primary deposit account held by JPMorgan Chase Bank, N.A., London Branch (the “Depository”). The Sponsor is a Delaware limited liability company whose sole member is Invesco Capital Management. The Sponsor is responsible for, among other things, overseeing the performance of The Bank of New York Mellon (the “Trustee”) and the Trust’s principal service providers, including the preparation of financial statements. The Trustee is responsible for the day-to-day administration of the Trust.

The investment objective of the Trust is for the Trust’s shares (the “Shares”) to reflect the price in U.S. Dollars (“USD”) of the Swiss Franc plus accrued interest, if any, less the Trust’s expenses and liabilities. The Shares are intended to provide investors with a simple, cost-effective means of gaining investment benefits similar to those of holding Swiss Francs. The Trust’s assets primarily consist of Swiss Francs on demand deposit in two deposit accounts maintained by the Depository: a primary deposit account which may earn interest and a secondary deposit account which does not earn interest. The secondary deposit account is used to account for any interest that may be received and paid out on creations and redemptions of blocks of 50,000 Shares (“Baskets”). The secondary account is also used to account for interest earned, if any, on the primary deposit account, pay Trust expenses and distribute any excess interest to holders of Shares (“Shareholders”) on a monthly basis.

The accompanying unaudited financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission. In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period. These financial statements and the notes thereto should be read in conjunction with the Trust’s financial statements included in the Form 10-K transition report as filed on March 11, 2019.

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Significant Accounting Policies
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Significant Accounting Policies

3.

Significant Accounting Policies

 

A.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets, liabilities and disclosures of contingent liabilities at the date of the financial statements, the reported amounts of revenue and expenses during the period and the evaluation of subsequent events through the issuance date of the financial statements. Actual results could differ from those estimates.

 

B.

Foreign Currency Translation

For Net Asset Value (“NAV”) calculation purposes, Swiss Franc deposits (cash) are translated at the Closing Spot Rate, which is the Swiss Franc/USD exchange rate as determined and published by The WM Company at 4:00 PM (London time / London fixing) on each day that NYSE Arca, Inc. (“NYSE Arca”) is open for regular trading.

The Trust maintains its books and records in Swiss Francs. For financial statement reporting purposes, the U.S. Dollar is the reporting currency. As a result, the financial records of the Trust are translated from Swiss Francs to USD. The Closing Spot Rate on the last day of the period is used for translation in the statements of financial condition. The average Closing Spot Rate for the period is used for translation in the statements of comprehensive income and the statements of cash flows. The redeemable capital Shares are adjusted to redemption value and these adjustments are recorded against retained earnings.

 

C.

Federal Income Taxes

The Trust is treated as a “grantor trust” for federal income tax purposes and, therefore, no provision for federal income taxes is required. Interest, gains and losses are passed through to the Shareholders.

Shareholders generally will be treated, for U.S. federal income tax purposes, as if they directly owned a pro-rata share of the assets held in the Trust. Shareholders also will be treated as if they directly received their respective pro-rata portion of the Trust’s income, if any, and as if they directly incurred their respective pro-rata portion of the Trust’s expenses. The acquisition of Shares by a U.S. Shareholder as part of a creation of a Basket will not be a taxable event to the Shareholder.

The Sponsor’s fee accrues daily and is payable monthly. For U.S. federal income tax purposes, an accrual-basis U.S. Shareholder generally will be required to take into account as an expense its allocable portion of the USD-equivalent of the amount of the Sponsor’s fee that is accrued on each day, with such USD-equivalent being determined by the currency exchange rate that is in effect on the respective day. To the extent that the currency exchange rate on the date of payment of the accrued amount of the Sponsor’s fee differs from the currency exchange rate in effect on the day of accrual, the U.S. Shareholder will recognize a currency gain or loss for U.S. federal income tax purposes.

The Trust does not expect to generate taxable income except for interest income (if any) and gain (if any) upon the sale of Swiss Francs. A non-U.S. Shareholder generally will not be subject to U.S. federal income tax with respect to gain recognized upon the sale or other disposition of Shares, or upon the sale of Swiss Francs by the Trust, unless: (1) the non-U.S. Shareholder is an individual and is present in the United States for 183 days or more during the taxable year of the sale or other disposition, and the gain is treated as being from United States sources; or (2) the gain is effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States.

A non-U.S. Shareholder’s portion of any interest income earned by the Trust generally will not be subject to U.S. federal income tax unless the Shares owned by such non-U.S. Shareholder are effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States.

 

D.

Revenue Recognition

Interest on the primary deposit account, if any, accrues daily as earned and is received or paid on a monthly basis. Any interest below zero for the period is reflected as interest expense on currency deposits. The Depository may change the rate at which interest accrues, including reducing the interest rate to zero or below zero, based upon changes in market conditions or based on the Depository’s liquidity needs. Interest charged on the primary deposit account will be disclosed as interest expense on currency deposits.

 

E.

Dividends

To the extent that the interest earned by the Trust, if any, exceeds the sum of the Sponsor’s fee for the prior month plus other Trust expenses, if any, the Trust will distribute, as a dividend (herein referred to as dividends or distributions), the excess interest earned in Swiss Francs effective on the first business day of the subsequent month. The Trustee will direct that the excess Swiss Francs be converted into USD at the prevailing market rate and the Trustee will distribute the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own).

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Swiss Franc Deposits
3 Months Ended
Mar. 31, 2019
Cash And Cash Equivalents [Abstract]  
Swiss Franc Deposits

4.

Swiss Franc Deposits

Swiss Franc principal deposits are held in a Swiss Franc-denominated, interest-bearing demand account. The interest rate in effect as of March 31, 2019 was an annual nominal rate of -0.75%. For the three months ended March 31, 2019, there were Swiss Franc principal deposits of 9,312,870, Swiss Franc principal redemptions of 32,604,681 and Swiss Franc withdrawals (to pay expenses) of 478,390, resulting in an ending Swiss Franc principal balance of 148,938,249. This equates to 149,551,411 USD. For the two months ended December 31, 2018, there were Swiss Franc principal deposits of 18,683,840, Swiss Franc principal redemptions of 23,343,201 and Swiss Franc withdrawals (to pay expenses) of 345,547, resulting in an ending Swiss Franc principal balance of 172,708,450. This equates to 175,196,237 USD.

Net interest, if any, associated with creation and redemption activity is held in a Swiss Franc-denominated non-interest-bearing account, and any balance is distributed in full as part of the monthly income distributions, if any.

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Capital Shares
3 Months Ended
Mar. 31, 2019
Federal Home Loan Banks [Abstract]  
Redeemable Capital Shares

5. Redeemable Capital Shares

Shares are classified as “redeemable” for financial statement purposes, since they are subject to redemption. Shares are issued and redeemed continuously in Baskets in exchange for Swiss Francs. Individual investors cannot purchase or redeem Shares in direct transactions with the Trust. Only Authorized Participants (as defined below) may place orders to create and redeem Baskets. An Authorized Participant is a Depository Trust Company (“DTC”) participant that is a registered broker-dealer or other institution eligible to settle securities transactions through the book-entry facilities of the DTC and which has entered into a contractual arrangement with the Trust and the Sponsor governing, among other matters, the creation and redemption process. Authorized Participants may redeem their Shares at any time in Baskets.

Due to expected continuing creations and redemptions of Baskets and the two-day period for settlement of each creation or redemption, the Trust reflects Shares created as a receivable on the trade date. Shares redeemed are reflected as a liability on the trade date. Outstanding Shares are reflected at a redemption value, which is the NAV per Share at the period end date. Adjustments to redeemable capital Shares at redemption value are recorded directly to redeemable capital shares and retained earnings.

Activity in redeemable capital Shares is as follows:

 

 

Three Months Ended March 31, 2019

 

 

Three Months Ended March 31, 2018

 

 

 

Shares

 

 

U.S. Dollar

Amount

 

 

Shares

 

 

 

 

U.S. Dollar

Amount

 

Opening Balance

 

 

1,850,000

 

 

$

175,017,674

 

 

 

1,550,000

 

 

 

 

$

150,066,823

 

Shares issued

 

 

100,000

 

 

 

9,316,175

 

 

 

100,000

 

 

 

 

 

9,922,904

 

Shares redeemed

 

 

(350,000

)

 

 

(32,867,039

)

 

 

 

 

 

 

 

 

Adjustment of Redeemable Capital Shares to Redemption Value

 

 

 

 

 

(2,063,367

)

 

 

 

 

 

 

 

2,113,881

 

Ending Balance

 

 

1,600,000

 

 

$

149,403,443

 

 

 

1,650,000

 

 

 

 

 

162,103,608

 

The Trustee calculates the Trust’s NAV each business day. To calculate the NAV, the Trustee subtracts the Sponsor’s accrued fee through the previous day from the Swiss Francs held by the Trust (including all unpaid interest, if any, accrued through the preceding day) and calculates the value of the Swiss Francs in USD based upon the Closing Spot Rate. If, on a particular evaluation day, the Closing Spot Rate has not been determined and announced by 6:00 PM (London time), then the most recent Closing Spot Rate will be used to determine the NAV of the Trust unless the Trustee, in consultation with the Sponsor, determines that such price is inappropriate to use as the basis for the valuation. If the Trustee and the Sponsor determine that the most recent Closing Spot Rate is not an appropriate basis for valuation of the Trust’s Swiss Francs, they will determine an alternative basis for the valuation. The Trustee also determines the NAV per Share, which equals the NAV of the Trust, divided by the number of outstanding Shares. Shares deliverable under a purchase order are considered outstanding for purposes of determining NAV per Share; Shares deliverable under a redemption order are not considered outstanding for this purpose.

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Related Parties
3 Months Ended
Mar. 31, 2019
Related Party Transactions [Abstract]  
Related Parties

6.Related Parties

The Sponsor is a related party of the Trust. The Sponsor’s fee accrues daily at an annual nominal rate of 0.40% of the Swiss Francs in the Trust (including all unpaid interest but excluding unpaid fees, each as accrued through the immediately preceding day) and is paid monthly.

The Sponsor assumes and pays the following administrative and marketing expenses incurred by the Trust: the Trustee’s monthly fee, NYSE Arca listing fees, SEC registration fees, typical maintenance and transaction fees of the Depository, printing and mailing costs, audit fees and expenses, up to $100,000 per year in legal fees and expenses, and applicable license fees.

In certain exceptional cases the Trust will pay for some expenses in addition to the Sponsor’s fee. These exceptions include expenses not assumed by the Sponsor (i.e., expenses other than those identified in the preceding paragraph), expenses resulting from negative interest rates, taxes and governmental charges, expenses and costs of any extraordinary services performed by the Trustee or the Sponsor on behalf of the Trust or action taken by the Trustee or the Sponsor to protect the Trust or the interests of Shareholders, indemnification of the Sponsor under the Depositary Trust Agreement, audit fees and legal expenses in excess of $100,000 per year.

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Concentration Risk
3 Months Ended
Mar. 31, 2019
Risks And Uncertainties [Abstract]  
Concentration Risk

7.

Concentration Risk

All of the Trust’s assets are Swiss Francs, which creates a concentration risk associated with fluctuations in the price of the Swiss Franc. Accordingly, a decline in the Swiss Franc to USD exchange rate will have an adverse effect on the value of the Shares. Factors that may have the effect of causing a decline in the price of the Swiss Franc include national debt levels and trade deficits, domestic and foreign inflation rates, domestic and foreign interest rates, investment and trading activities of institutions and global or regional political, economic or financial events and situations. Substantial sales of Swiss Francs by the official sector (central banks, other governmental agencies and related institutions that buy, sell and hold Swiss Francs as part of their reserve assets) could adversely affect an investment in the Shares.

All of the Trust’s Swiss Francs are held by the Depository. Accordingly, a risk associated with the concentration of the Trust’s assets in accounts held by a single financial institution exists and increases the potential for loss by the Trust and the Trust’s beneficiaries in the event that the Depository becomes insolvent.

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2019
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

8.

Commitments and Contingencies

The Trust’s organizational documents provide for the Trust to indemnify the Sponsor and any affiliate of the Sponsor that provides services to the Trust to the maximum extent permitted by applicable law, subject to certain exceptions for disqualifying conduct by the Sponsor or such an affiliate. The Trust’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Trust that have not yet occurred. Further, the Trust has not had prior claims or losses pursuant to these contracts. Accordingly, the Sponsor expects the risk of loss to be remote.

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Use of Estimates

 

A.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets, liabilities and disclosures of contingent liabilities at the date of the financial statements, the reported amounts of revenue and expenses during the period and the evaluation of subsequent events through the issuance date of the financial statements. Actual results could differ from those estimates.

Foreign Currency Translation

 

B.

Foreign Currency Translation

For Net Asset Value (“NAV”) calculation purposes, Swiss Franc deposits (cash) are translated at the Closing Spot Rate, which is the Swiss Franc/USD exchange rate as determined and published by The WM Company at 4:00 PM (London time / London fixing) on each day that NYSE Arca, Inc. (“NYSE Arca”) is open for regular trading.

The Trust maintains its books and records in Swiss Francs. For financial statement reporting purposes, the U.S. Dollar is the reporting currency. As a result, the financial records of the Trust are translated from Swiss Francs to USD. The Closing Spot Rate on the last day of the period is used for translation in the statements of financial condition. The average Closing Spot Rate for the period is used for translation in the statements of comprehensive income and the statements of cash flows. The redeemable capital Shares are adjusted to redemption value and these adjustments are recorded against retained earnings.

Federal Income Taxes

 

C.

Federal Income Taxes

The Trust is treated as a “grantor trust” for federal income tax purposes and, therefore, no provision for federal income taxes is required. Interest, gains and losses are passed through to the Shareholders.

Shareholders generally will be treated, for U.S. federal income tax purposes, as if they directly owned a pro-rata share of the assets held in the Trust. Shareholders also will be treated as if they directly received their respective pro-rata portion of the Trust’s income, if any, and as if they directly incurred their respective pro-rata portion of the Trust’s expenses. The acquisition of Shares by a U.S. Shareholder as part of a creation of a Basket will not be a taxable event to the Shareholder.

The Sponsor’s fee accrues daily and is payable monthly. For U.S. federal income tax purposes, an accrual-basis U.S. Shareholder generally will be required to take into account as an expense its allocable portion of the USD-equivalent of the amount of the Sponsor’s fee that is accrued on each day, with such USD-equivalent being determined by the currency exchange rate that is in effect on the respective day. To the extent that the currency exchange rate on the date of payment of the accrued amount of the Sponsor’s fee differs from the currency exchange rate in effect on the day of accrual, the U.S. Shareholder will recognize a currency gain or loss for U.S. federal income tax purposes.

The Trust does not expect to generate taxable income except for interest income (if any) and gain (if any) upon the sale of Swiss Francs. A non-U.S. Shareholder generally will not be subject to U.S. federal income tax with respect to gain recognized upon the sale or other disposition of Shares, or upon the sale of Swiss Francs by the Trust, unless: (1) the non-U.S. Shareholder is an individual and is present in the United States for 183 days or more during the taxable year of the sale or other disposition, and the gain is treated as being from United States sources; or (2) the gain is effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States.

A non-U.S. Shareholder’s portion of any interest income earned by the Trust generally will not be subject to U.S. federal income tax unless the Shares owned by such non-U.S. Shareholder are effectively connected with the conduct by the non-U.S. Shareholder of a trade or business in the United States.

Revenue Recognition

 

D.

Revenue Recognition

Interest on the primary deposit account, if any, accrues daily as earned and is received or paid on a monthly basis. Any interest below zero for the period is reflected as interest expense on currency deposits. The Depository may change the rate at which interest accrues, including reducing the interest rate to zero or below zero, based upon changes in market conditions or based on the Depository’s liquidity needs. Interest charged on the primary deposit account will be disclosed as interest expense on currency deposits.

Dividends

 

E.

Dividends

To the extent that the interest earned by the Trust, if any, exceeds the sum of the Sponsor’s fee for the prior month plus other Trust expenses, if any, the Trust will distribute, as a dividend (herein referred to as dividends or distributions), the excess interest earned in Swiss Francs effective on the first business day of the subsequent month. The Trustee will direct that the excess Swiss Francs be converted into USD at the prevailing market rate and the Trustee will distribute the USD as promptly as practicable to Shareholders on a pro-rata basis (in accordance with the number of Shares that they own).

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Capital Shares (Tables)
3 Months Ended
Mar. 31, 2019
Federal Home Loan Banks [Abstract]  
Schedule for Redeemable Capital Shares Activity

Activity in redeemable capital Shares is as follows:

 

 

Three Months Ended March 31, 2019

 

 

Three Months Ended March 31, 2018

 

 

 

Shares

 

 

U.S. Dollar

Amount

 

 

Shares

 

 

 

 

U.S. Dollar

Amount

 

Opening Balance

 

 

1,850,000

 

 

$

175,017,674

 

 

 

1,550,000

 

 

 

 

$

150,066,823

 

Shares issued

 

 

100,000

 

 

 

9,316,175

 

 

 

100,000

 

 

 

 

 

9,922,904

 

Shares redeemed

 

 

(350,000

)

 

 

(32,867,039

)

 

 

 

 

 

 

 

 

Adjustment of Redeemable Capital Shares to Redemption Value

 

 

 

 

 

(2,063,367

)

 

 

 

 

 

 

 

2,113,881

 

Ending Balance

 

 

1,600,000

 

 

$

149,403,443

 

 

 

1,650,000

 

 

 

 

 

162,103,608

 

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Description of the Trust - Additional Information (Detail)
3 Months Ended
Mar. 31, 2019
Depositor
shares
Jun. 08, 2006
CHF (SFr)
Organization Consolidation And Presentation Of Financial Statements [Abstract]    
Initial deposits by Sponsor, Primary deposit account | SFr   SFr 100
Incorporation date Jun. 08, 2006  
Number of deposits accounts in which trust's assets primarily consist of Swiss Francs | Depositor 2  
Redemptions Capital Shares, Number of shares in each Block | shares 50,000  
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Significant Accounting Policies - Additional Information (Detail)
3 Months Ended
Mar. 31, 2019
USD ($)
Accounting Policies [Abstract]  
Provision for federal income taxes $ 0
Number of days residing in country for income tax purpose 183 days
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Swiss Franc Deposits - Additional Information (Detail)
2 Months Ended 3 Months Ended
Dec. 31, 2018
CHF (SFr)
Mar. 31, 2019
USD ($)
Mar. 31, 2019
CHF (SFr)
Mar. 31, 2018
USD ($)
Mar. 31, 2019
CHF (SFr)
Dec. 31, 2018
USD ($)
Dec. 31, 2018
CHF (SFr)
Cash And Cash Equivalents [Abstract]              
Principal deposits SFr 18,683,840 $ 9,316,175 SFr 9,312,870 $ 9,922,904      
Principal redemptions 23,343,201 32,867,039 32,604,681 $ 0      
Withdrawals (to pay expenses) SFr 345,547   SFr 478,390        
Deposits, interest bearing   $ 149,551,411     SFr 148,938,249 $ 175,196,237 SFr 172,708,450
Annual nominal rate   (0.75%) (0.75%)        
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Capital Shares - Additional Information (Detail)
3 Months Ended
Mar. 31, 2019
Temporary Equity Disclosure [Abstract]  
Redeemable capital shares settlement period creation and redemption 2 days
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Redeemable Capital Shares - Schedule for Redeemable Capital Shares Activity (Detail) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Temporary Equity Disclosure [Abstract]    
Opening Balance, Shares 1,850,000 1,550,000
Balance $ 175,017,674 $ 150,066,823
Shares issued, Shares 100,000 100,000
Purchases of Shares $ 9,316,175 $ 9,922,904
Shares redeemed, Shares (350,000)  
Redemption of Shares $ (32,867,039)  
Adjustment of Redeemable Capital Shares to Redemption Value $ (2,063,367) $ 2,113,881
Ending Balance, Shares 1,600,000 1,650,000
Balance $ 149,403,443 $ 162,103,608
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Related Parties - Additional Information (Detail) - Sponsor [Member]
3 Months Ended
Mar. 31, 2019
USD ($)
Accrued Professional Fees [Member]  
Related Party Transaction [Line Items]  
Sponsor's fee accrues daily and paid monthly, annual nominal Rate 0.40%
Professional Fees Liability [Member]  
Related Party Transaction [Line Items]  
Legal fees and expenses assumed $ 100,000
Excess amount of assumed audit fees and legal expenses $ 100,000
XML 37 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 39 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 18 80 1 false 5 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.currencyshares.com/20190331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Statements of Financial Condition (Unaudited) Sheet http://www.currencyshares.com/20190331/taxonomy/role/StatementStatementsOfFinancialConditionUnaudited Statements of Financial Condition (Unaudited) Statements 2 false false R3.htm 100020 - Statement - Statements of Financial Condition (Parenthetical) (Unaudited) Sheet http://www.currencyshares.com/20190331/taxonomy/role/StatementStatementsOfFinancialConditionParentheticalUnaudited Statements of Financial Condition (Parenthetical) (Unaudited) Statements 3 false false R4.htm 100030 - Statement - Statements of Comprehensive Income (Unaudited) Sheet http://www.currencyshares.com/20190331/taxonomy/role/StatementStatementsOfComprehensiveIncomeUnaudited Statements of Comprehensive Income (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Statements of Changes in Shareholders' Equity and Redeemable Capital Shares (Unaudited) Sheet http://www.currencyshares.com/20190331/taxonomy/role/StatementStatementsOfChangesInShareholdersEquityAndRedeemableCapitalSharesUnaudited Statements of Changes in Shareholders' Equity and Redeemable Capital Shares (Unaudited) Statements 5 false false R6.htm 100050 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.currencyshares.com/20190331/taxonomy/role/StatementStatementsOfCashFlowsUnaudited Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 100060 - Disclosure - Background Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureBackground Background Notes 7 false false R8.htm 100070 - Disclosure - Organization and Description of the Trust Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureOrganizationAndDescriptionOfTrust Organization and Description of the Trust Notes 8 false false R9.htm 100080 - Disclosure - Significant Accounting Policies Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Swiss Franc Deposits Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureSwissFrancDeposits Swiss Franc Deposits Notes 10 false false R11.htm 100100 - Disclosure - Redeemable Capital Shares Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRedeemableCapitalShares Redeemable Capital Shares Notes 11 false false R12.htm 100110 - Disclosure - Related Parties Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRelatedParties Related Parties Notes 12 false false R13.htm 100120 - Disclosure - Concentration Risk Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureConcentrationRisk Concentration Risk Notes 13 false false R14.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100140 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.currencyshares.com/20190331/taxonomy/role/DisclosureSignificantAccountingPolicies 15 false false R16.htm 100150 - Disclosure - Redeemable Capital Shares (Tables) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRedeemableCapitalSharesTables Redeemable Capital Shares (Tables) Tables http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRedeemableCapitalShares 16 false false R17.htm 100160 - Disclosure - Organization and Description of the Trust - Additional Information (Detail) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureOrganizationAndDescriptionOfTrustAdditionalInformationDetail Organization and Description of the Trust - Additional Information (Detail) Details 17 false false R18.htm 100170 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 18 false false R19.htm 100180 - Disclosure - Swiss Franc Deposits - Additional Information (Detail) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureSwissFrancDepositsAdditionalInformationDetail Swiss Franc Deposits - Additional Information (Detail) Details 19 false false R20.htm 100190 - Disclosure - Redeemable Capital Shares - Additional Information (Detail) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRedeemableCapitalSharesAdditionalInformationDetail Redeemable Capital Shares - Additional Information (Detail) Details 20 false false R21.htm 100200 - Disclosure - Redeemable Capital Shares - Schedule for Redeemable Capital Shares Activity (Detail) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRedeemableCapitalSharesScheduleForRedeemableCapitalSharesActivityDetail Redeemable Capital Shares - Schedule for Redeemable Capital Shares Activity (Detail) Details 21 false false R22.htm 100210 - Disclosure - Related Parties - Additional Information (Detail) Sheet http://www.currencyshares.com/20190331/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail Related Parties - Additional Information (Detail) Details 22 false false All Reports Book All Reports fxf-20190331.xml fxf-20190331.xsd fxf-20190331_cal.xml fxf-20190331_def.xml fxf-20190331_lab.xml fxf-20190331_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 42 0001564590-19-017426-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-19-017426-xbrl.zip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end